Carlo Brouwer

1.2k total citations
24 papers, 717 citations indexed

About

Carlo Brouwer is a scholar working on Microbiology, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Carlo Brouwer has authored 24 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Microbiology, 9 papers in Molecular Biology and 9 papers in Nutrition and Dietetics. Recurrent topics in Carlo Brouwer's work include Antimicrobial Peptides and Activities (18 papers), Infant Nutrition and Health (9 papers) and Antifungal resistance and susceptibility (6 papers). Carlo Brouwer is often cited by papers focused on Antimicrobial Peptides and Activities (18 papers), Infant Nutrition and Health (9 papers) and Antifungal resistance and susceptibility (6 papers). Carlo Brouwer collaborates with scholars based in Netherlands, Italy and United States. Carlo Brouwer's co-authors include Mick M. Welling, Peter H. Nibbering, Antonella Lupetti, Jaap T. van Dissel, Sylvia J. P. Bogaards, Akke Paulusma-Annema, Marty Wulferink, Ernest K. J. Pauwels, Arie V. Nieuw Amerongen and Sonia Senesi and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Carlo Brouwer

23 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlo Brouwer Netherlands	15	409	271	155	129	101	24	717
Alessandra Frioni Italy	13	90 0.2×	136 0.5×	363 2.3×	106 0.8×	135 1.3×	14	692
Agostina Pietrantoni Italy	16	109 0.3×	210 0.8×	394 2.5×	58 0.4×	302 3.0×	26	774
Judy K. Morona Australia	17	358 0.9×	457 1.7×	64 0.4×	51 0.4×	140 1.4×	22	1.4k
Abed Athamna Israel	15	80 0.2×	241 0.9×	45 0.3×	129 1.0×	85 0.8×	26	755
Kyle J. Wayne United States	11	176 0.4×	321 1.2×	36 0.2×	43 0.3×	152 1.5×	11	855
Louise Zeuthen Denmark	11	114 0.3×	475 1.8×	111 0.7×	67 0.5×	166 1.6×	12	942
I Engberg Sweden	11	110 0.3×	325 1.2×	230 1.5×	113 0.9×	82 0.8×	13	1.2k
Mayumi K. Holly United States	9	126 0.3×	208 0.8×	35 0.2×	23 0.2×	137 1.4×	9	555
A. M. J. J. Verweij-Van Vught Netherlands	15	126 0.3×	299 1.1×	52 0.3×	41 0.3×	174 1.7×	33	911
Izabela Glegola-Madejska United Kingdom	11	83 0.2×	325 1.2×	26 0.2×	57 0.4×	168 1.7×	11	564

Countries citing papers authored by Carlo Brouwer

Since Specialization

Citations

This map shows the geographic impact of Carlo Brouwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Brouwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Brouwer more than expected).

Fields of papers citing papers by Carlo Brouwer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Brouwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Brouwer. The network helps show where Carlo Brouwer may publish in the future.

Co-authorship network of co-authors of Carlo Brouwer

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Brouwer. A scholar is included among the top collaborators of Carlo Brouwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Brouwer. Carlo Brouwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brouwer, Carlo, Mick M. Welling, Saleh Alwasel, & Teun Boekhout. (2025). Potential health benefits of lactoferrin and derived peptides – how to qualify as a medical device?. Critical Reviews in Microbiology. 51(6). 1041–1065. 1 indexed citations

Brouwer, Carlo, et al.. (2025). Synthetic Human Lactoferrin Peptide hLF(1-11) Shows Antifungal Activity and Synergism with Fluconazole and Anidulafungin Towards Candida albicans and Various Non-Albicans Candida Species, Including Candidozyma auris. Antibiotics. 14(7). 671–671.

Brouwer, Carlo. (2024). Screening sensibility and antifungal activity after topical application of a synthetic lactoferrin-derived antimicrobial peptide. American Journal of Translational Research. 16(2). 669–680. 4 indexed citations

Brouwer, Carlo, Bart Theelen, Saleh Alwasel, et al.. (2024). Combinatory Use of hLF(1-11), a Synthetic Peptide Derived from Human Lactoferrin, and Fluconazole/Amphotericin B against Malassezia furfur Reveals a Synergistic/Additive Antifungal Effect. Antibiotics. 13(8). 790–790. 3 indexed citations

Arastehfar, Amir, Farnaz Daneshnia, Mohammadreza Salehi, et al.. (2019). Corrigendum: Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples – an Iranian multicentre study and a review of the literature. Journal of Medical Microbiology. 68(11). 1695–1695. 1 indexed citations

Brouwer, Carlo. (2018). Structure-Activity Relationship Study of Synthetic Variants Derived from the Highly Potent Human Antimicrobial Peptide hLF(1-11). INFM-OAR (INFN Catania). 1(3). 14 indexed citations

Brouwer, Carlo, Miaomiao Zhou, Gianluigi Cardinali, et al.. (2016). Current Opportunities and Challenges of Next Generation Sequencing (NGS) of DNA; Determining Health and Diseases. British Biotechnology Journal. 13(4). 1–17. 3 indexed citations

Ozturkoglu‐Budak, Sebnem, Miaomiao Zhou, Carlo Brouwer, et al.. (2014). A genomic survey of proteases in Aspergilli. BMC Genomics. 15(1). 523–523. 38 indexed citations

Brouwer, Carlo, et al.. (2011). Discovery and development of a synthetic peptide derived from lactoferrin for clinical use. Peptides. 32(9). 1953–1963. 72 indexed citations

10.

Brouwer, Carlo, et al.. (2010). Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis.. PubMed. 54(4). 442–50. 13 indexed citations

11.

Lupetti, Antonella, Jaap T. van Dissel, Carlo Brouwer, & Peter H. Nibbering. (2008). Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus. European Journal of Clinical Microbiology & Infectious Diseases. 27(11). 1125–1129. 46 indexed citations

12.

Brouwer, Carlo & Mick M. Welling. (2008). Various routes of administration of 99mTc-labeled synthetic lactoferrin antimicrobial peptide hLF 1–11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice. Peptides. 29(7). 1109–1117. 20 indexed citations

13.

Brouwer, Carlo, Marty Wulferink, & Mick M. Welling. (2007). The Pharmacology of Radiolabeled Cationic Antimicrobial Peptides. Journal of Pharmaceutical Sciences. 97(5). 1633–1651. 22 indexed citations

14.

Lupetti, Antonella, Carlo Brouwer, Sylvia J. P. Bogaards, et al.. (2007). Human Lactoferrin‐Derived Peptide's Antifungal Activities against DisseminatedCandida albicansInfection. The Journal of Infectious Diseases. 196(9). 1416–1424. 58 indexed citations

15.

Welling, Mick M., Carlo Brouwer, Wim van ‘t Hof, Enno C.I. Veerman, & Arie V. Nieuw Amerongen. (2007). Histatin-Derived Monomeric and Dimeric Synthetic Peptides Show Strong Bactericidal Activity towards Multidrug-Resistant Staphylococcus aureus In Vivo. Antimicrobial Agents and Chemotherapy. 51(9). 3416–3419. 39 indexed citations

16.

Brouwer, Carlo, Sylvia J. P. Bogaards, Marty Wulferink, Markwin P. Velders, & Mick M. Welling. (2006). Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice. Peptides. 27(11). 2585–2591. 51 indexed citations

17.

Stallmann, Hein P., A.L.J.J. Bronckers, J.M.A. de Blieck-Hogervorst, et al.. (2005). Histatin and lactoferrin derived peptides: Antimicrobial properties and effects on mammalian cells. Peptides. 26(12). 2355–2359. 44 indexed citations

18.

Lupetti, Antonella, Carlo Brouwer, Sonia Senesi, et al.. (2004). Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin. Journal of Antimicrobial Chemotherapy. 54(3). 603–608. 20 indexed citations

19.

Dijkshoorn, Lenie, Carlo Brouwer, Sylvia J. P. Bogaards, et al.. (2004). The Synthetic N-Terminal Peptide of Human Lactoferrin, hLF(1-11), Is Highly Effective against Experimental Infection Caused by Multidrug-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 48(12). 4919–4921. 70 indexed citations

20.

Lupetti, Antonella, Akke Paulusma-Annema, Mick M. Welling, et al.. (2002). Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species. Antimicrobial Agents and Chemotherapy. 47(1). 262–267. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact